72 related articles for article (PubMed ID: 15114278)
1. Navigational bronchoscopy with biopsy versus computed tomography-guided biopsy for the diagnosis of a solitary pulmonary nodule: a cost-consequences analysis.
Dale CR; Madtes DK; Fan VS; Gorden JA; Veenstra DL
J Bronchology Interv Pulmonol; 2012 Oct; 19(4):294-303. PubMed ID: 23207529
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of CT-Guided Percutaneous Pulmonary Biopsy for Distinguishing Benign and Malignant Solitary Pulmonary Nodules.
Li X; Jin F; Zhou T; Ru Y; Gu F; Wang L; Chen J
Altern Ther Health Med; 2023 Nov; 29(8):918-923. PubMed ID: 37773650
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast enhanced CT in nodule characterization: How we review and report.
Qureshi NR; Shah A; Eaton RJ; Miles K; Gilbert FJ;
Cancer Imaging; 2016 Jul; 16(1):16. PubMed ID: 27430260
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies.
Stefanidis K; Bellos I; Konstantelou E; Yusuf G; Hardavella G; Jacob T; Goldman A; Senbanjo T; Vlahos I
Eur J Radiol; 2024 Feb; 171():111315. PubMed ID: 38237515
[TBL] [Abstract][Full Text] [Related]
5. Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
Fernandes S; Williams G; Williams E; Ehrlich K; Stone J; Finlayson N; Bradley M; Thomson RR; Akram AR; Dhaliwal K
Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33060152
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.
Qureshi NR; Rintoul RC; Miles KA; George S; Harris S; Madden J; Cozens K; Little LA; Eichhorst K; Jones J; Moate P; McClement C; Pike L; Sinclair D; Wong WL; Shekhdar J; Eaton R; Shah A; Brindle L; Peebles C; Banerjee A; Dizdarevic S; Han S; Poon FW; Groves AM; Kurban L; Frew AJ; Callister ME; Crosbie P; Gleeson FV; Karunasaagarar K; Kankam O; Gilbert FJ
BMJ Open Respir Res; 2016; 3(1):e000156. PubMed ID: 27843550
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of solitary pulmonary nodule detected during computed tomography examination.
Choromańska A; Macura KJ
Pol J Radiol; 2012 Apr; 77(2):22-34. PubMed ID: 22844306
[TBL] [Abstract][Full Text] [Related]
9. Inpatient FDG PET/CT: Point-A Strategic Path to Patient-Centered, Yet Cost-Effective, Care.
Szidonya L; Mallak N
AJR Am J Roentgenol; 2024 Jan; ():. PubMed ID: 38197758
[No Abstract] [Full Text] [Related]
10. Navigational Bronchoscopy for Early Lung Cancer: A Road to Therapy.
Khan KA; Nardelli P; Jaeger A; O'Shea C; Cantillon-Murphy P; Kennedy MP
Adv Ther; 2016 Apr; 33(4):580-96. PubMed ID: 27084723
[TBL] [Abstract][Full Text] [Related]
11. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease.
Grogan EL; Weinstein JJ; Deppen SA; Putnam JB; Nesbitt JC; Lambright ES; Walker RC; Dittus RS; Massion PP
J Thorac Oncol; 2011 Oct; 6(10):1720-5. PubMed ID: 21760552
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.
Yap KK; Yap KS; Byrne AJ; Berlangieri SU; Poon A; Mitchell P; Knight SR; Clarke PC; Harris A; Tauro A; Rowe CC; Scott AM
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1033-40. PubMed ID: 15875178
[TBL] [Abstract][Full Text] [Related]
13. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
Tsushima Y; Endo K
Med Sci Monit; 2004 May; 10(5):MT65-72. PubMed ID: 15114278
[TBL] [Abstract][Full Text] [Related]
14. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
Keith CJ; Miles KA; Griffiths MR; Wong D; Pitman AG; Hicks RJ
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1016-23. PubMed ID: 12173015
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
Gould MK; Sanders GD; Barnett PG; Rydzak CE; Maclean CC; McClellan MB; Owens DK
Ann Intern Med; 2003 May; 138(9):724-35. PubMed ID: 12729427
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach KW; Schicha H
Eur J Nucl Med; 2000 Oct; 27(10):1441-56. PubMed ID: 11083532
[TBL] [Abstract][Full Text] [Related]
17. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
Li W; Pang H; Liu Q; Zhou J
Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866
[TBL] [Abstract][Full Text] [Related]
18. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
